Jazz Pharmaceuticals Announces Second Quarter 2018 Financial Results

Go back to Jazz Pharmaceuticals Announces Second Quarter 2018 Financial Results
JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) Delayed: 245.57 +1.86 (0.76%)
Previous Close $243.71    52 Week High $160.00 
Open $244.00    52 Week Low $95.80 
Day High $248.07    P/E 45.64 
Day Low $241.02    EPS $5.38 
Volume 1,155,945